2-(Cyclopent-1-en-1-yl)acetonitrile

Catalog No. :
ACLXZM279
CAS No. :
22734-04-9
Molecular Formula :
C7H9N
Molecular Weight :
107.16

IUPAC Name:2-(cyclopent-1-en-1-yl)acetonitrile

2-(Cyclopent-1-en-1-yl)acetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g90%$79.00Login to see priceIn stockInquiry
25g90%$261.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclopent-1-en-1-yl)acetonitrile
IUPAC Name2-(cyclopent-1-en-1-yl)acetonitrile
MDL No.MFCD00001398
Molecular FormulaC7H9N
Molecular Weight107.16
SMILESN#CCC1=CCCC1
InChI KeyLEWVRAMNXUWSFL-UHFFFAOYSA-N
SynonymD89377 | (1-Cyclopenten-1-yl)-acetonitrile | 1-Cyclopentenylacetonitrile | CS-0186442 | EN300-20436 | AKOS000119422 | 1-Cyclopentene-1-acetonitrile | 1-Cyclopenteneacetonitrile | 2-(cyclopenten-1-yl)acetonitrile | J-014828 | InChI=1/C7H9N/c8-6-5-7-3-1-2-4
CAS No.22734-04-9
PubChem CID89811

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H227-H301-H315-H319
Precautionary Statement(s)
P210-P261-P264-P270-P271-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311-P305+P351+P338-P332+P313-P337+P313-P362-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACLXZM279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACLXZM279 route product structure diagram
    ACLXZM27922734-04-9 In Stock
Inquiry

2. ACLXZM279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACLXZM279 route product structure diagram
    ACLXZM27922734-04-9 In Stock
Inquiry

Comments (0)